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Extracts from Nigella arvensis L. seeds, which are widely used as anti-inflammatory
remedies in traditional medicine of Northern Africa, were able to inhibit the expression
of the pro-inflammatory neutrophil chemokine Interleukin (IL)-8 in Cystic Fibrosis (CF)
bronchial epithelial IB3-1 cells exposed to the Gram-negative bacterium Pseudomonas
aeruginosa. The chemical composition of the extracts led to the identification of three
major components, β-sitosterol, stigmasterol, and campesterol, which are the most
abundant phytosterols, cholesterol-like molecules, usually found in plants. β-sitosterol
(BSS) was the only compound that significantly reproduced the inhibition of the
P. aeruginosa-dependent expression of IL-8 at nanomolar concentrations. BSS was
tested in CF airway epithelial CuFi-1 cells infected with P. aeruginosa. BSS (100 nM),
showed a significant and consistent inhibitory activity on expression of the P. aeruginosa-
stimulated expression chemokines IL-8, GRO-α GRO-β, which play a pivotal role in the
recruitment of neutrophils in CF inflamed lungs. Preliminary mechanistic analysis showed
that BSS partially inhibits the P. aeruginosa-dependent activation of Protein Kinase C
isoform alpha, which is known to be involved in the transmembrane signaling activating
IL-8 gene expression in bronchial epithelial cells. These data indicate BSS as a promising
molecule to control excessive lung inflammation in CF patients.
Keywords: Nigella arvensis, cystic fibrosis, inflammation, interleukin-8, cytokines, β-sitosterol
INTRODUCTION
Medicinal plants are attracting a renewed interest, since they have been a classical
source of drugs for different human diseases (Newman and Cragg, 2016). This interest is
particularly actual as the introduction of new drugs is now largely adopting the repurposing
strategy to overcome the bottlenecks of pharmaceutical development (Strittmatter, 2014),
a strategy that includes the natural medicinal products as potential repurposing source
(Cragg et al., 2014). By serendipity, we focused our attention on the seeds obtained
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from the plant Nigella arvensis (N. arvensis), that is commonly
known in native populations of Northern Africa and Asia
as curative plant in traditional medicine, as its black seeds
have been in use as natural remedy for over twenty centuries.
The plant Nigella is a genre of different species, including
N. sativa, N. damascena, and N. arvensis. Few findings were
reported about extracts derived from N. arvensis or active
principles identified in this species, while N. sativa was the
object of different studies, reporting on different biological
effects including its anti-inflammatory activities (Khader and
Eckl, 2014). Regarding the possible anti-inflammatory effects
of extracts derived from Nigella species, it has been published
that N. sativa has therapeutic and anti-oxidant effects during
lipopolysaccharide (LPS)-induced in vivo inflammation (Entok
et al., 2014). The major biological effects of N. sativa are attributed
to its characterized constituents, including thymoquinone, the
most prominent constituent of N. sativa seeds. Thymoquinone
is capable to reduce pro-inflammatory cytokine levels (Bai et al.,
2014). In addition to thymoquinone, Nigella seeds contain sterols,
proteins, alkaloids, saponins, and essential oils (Khader and Eckl,
2014).
Cystic Fibrosis (CF) is a severe genetic disease due to defects
of the CF Transmembrane Conductance Regulator (CFTR) gene,
affecting several organs. Chronic pulmonary disease is the leading
cause of reduced quality and expectancy of life (Pittman et al.,
2014). It is well established that chronic infection sustained
by the Gram-negative bacterium Pseudomonas aeruginosa
(P. aeruginosa) is a hallmark of CF lung disease, which is
associated with an excessive lung inflammation characterized by
huge infiltrate of neutrophils in the bronchial lumen, mainly due
to the release of the neutrophil chemokine IL-8 (Bonfield et al.,
1995; Khan et al., 1995; Puchelle et al., 2001; Belcher and Vij,
2010). The research regarding modern therapies to neutralize the
inflammation in CF patients is aimed at finding new putative
anti-inflammatory drugs displaying different mechanisms of
action, in order to replace corticosteroids or ibuprofen, which
posses many well-known and important side effects in addition
to the great predicted benefits (Cantin et al., 2015).
The large use of the “black seeds of the desert” to mitigate
the respiratory symptoms in Northern African children affected
by recurrent or chronic bronchial inflammatory diseases (as
anecdotal example see Supplementary Text S1), prompted us
to ascertain the potential anti-inflammatory properties of these
seeds. Due to the unmet need of novel anti-inflammatory drugs
for chronic lung disease of CF patients, we tested the chloroform
extract and the major chemical components of these seeds in
CF bronchial epithelial cells, which are known to play a pivotal
role in IL-8 expression and in the inflammatory response in
this condition (Prandini et al., 2016). We identified N. arvensis
as the plant originating the seeds utilized in current medicinal
practice, observing that its chloroform extract is effective to
reduce the expression of the key neutrophilic chemokine IL-8
in CF bronchial epithelial cells, upon exposure to P. aeruginosa.
Among the major chemical components isolated from the seeds
of N. arvensis, only β-sitosterol (BSS) was able to inhibit the
expression of the neutrophil chemokines IL-8, GRO-α, and
GRO-β, likely interfering with the protein kinase C-mediated
signaling. These results indicate BSS as a promising molecule to
control excessive lung inflammation in CF patients.
MATERIALS AND METHODS
Extraction of Chemical Components
from Nigella arvensis Seeds
Seeds of N. arvensis L. (Ranunculaceae) were purchased from a
Berberian pharmacy in Northern Africa (Morocco). N. arvensis
dried seeds (5.0 g) were milled in a blade grinder (0.2 mm mesh;
Fritsch, Idar-Oberstein, Germany). The flour was extracted with
50 ml of hexane through ultrasound assisted maceration (20 min
at 25◦C), then filtered and centrifuged (3,000 rpm, 20 min). The
residue was extracted with 50 ml of chloroform with the same
procedure, was then re-extracted twice with 25 ml of the same
solvent, for two times. All the supernatants were dried with rotary
evaporator.
Separation and Identification of
Chemical Components by GC-MS
Analysis
The chloroform extract was analyzed by a Varian GC-3800
gas chromatograph equipped with a Varian MS-4000 mass
spectrometer (MS) using electron impact and hooked to NIST
library. The column used was a Varian FactorFour VF-5ms poly-
5% phenyl-95%-dimethyl-siloxane bonded phase (i.d., 0.25 mm;
length, 30 m; film thickness, 0.25 µm). Operating conditions
for determination of chloroform extract composition were as
follows: injector temperature, 300◦C; carrier (helium) flow
rate, 1.5 mL/min and split ratio, 1:50. Oven temperature was
increased from 230 to 320◦C at a rate of 5◦C/min, followed
by 7 min at 320◦C. The MS conditions were: ionization
voltage, 70 eV; emission current, 10 mAmp; scan rate, 1 scan/s;
mass range, 29–600 Da; trap temperature, 150◦C, transfer line
temperature, 300◦C. One microliter of each sample was injected.
The constituents were identified by comparing their relative
retention time (KI) and the MS fragmentation patterns with
pure compounds (BSS, stigmasterol, and campesterol; Sigma–
Aldrich), by matching with the above mentioned mass spectra
library and with those in the literature (Adams, 2007). Samples
were analyzed in Gas Chromatography – Flame Ionization
Detector (GC-FID) for quantitative assessment through the
normalization method, without using correction factors. The
relative peak areas for individual constituents were averaged on
three different chromatograms. The relative percentages were
determined using a ThermoQuest GC-Trace gas-chromatograph
equipped with a FID detector maintained at 300◦C; all the others
GC conditions were the same of GC-MS method.
Cell Cultures and Bacteria
IB3-1 cells (LGC Promochem Europe) are human bronchial
epithelial cells immortalized with adeno12/SV40, derived from a
CF patient with a mutant F508del/W1282X genotype. Cells were
grown in the basal medium Laboratory of Human Carcinogenesis
(LHC)-8 (Biofluids, Rockville, MO, USA) supplemented with
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5% FBS. All culture flasks and plates were coated with a
solution containing 35 µg/ml bovine collagen (BD Biosciences,
Franklin Lakes, NJ, USA), 1 µg/ml BSA (Sigma–Aldrich), and
1 µg/ml human fibronectin (BD Biosciences). CuFi-1 cells,
kindly donated by A. Klingelhutz, P. Karp, and J. Zabner
(University of Iowa, Iowa City, IA, USA), have been derived from
bronchial epithelia of a patient affected by CF (CFTR mutant
genotype F508del/F508del), and were transformed by reverse
FIGURE 1 | Chemical structures of major compounds identified in extracts from Nigella arvensis. (A) N. arvensis. (B) GC/MS profile of chloroform extract.
(C) Chemical structures of β-sitosterol, stigmasterol, and campesterol.
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TABLE 1 | Compounds identified in chloroform extract.
Compounds Area % rt
Stigmastan-3,5-diene 8.53 13.00 Tentatively identified
Campesterol 2.42 14.66 Validated by the comparison with
the pure standard
Stigmasterol 13.73 14.95 Validated by the comparison with
the pure standard
β-Sitosterol 75.31 15.68 Validated by the comparison with
the pure standard
Compounds listed according to their elution on VF5 column.
transcriptase component of telomerase, hTERT, and human
papillomavirus type 16 E6 and E7 gene. These cells were grown on
human placental collagen type IV (Sigma–Aldrich)-coated flasks
in bronchial epithelial growth medium (Cambrex Bioscience,
Walkersville, MD, USA). CuFi-1 cells were also cultured into cell
culture inserts (pore size of 0.4 mm) in Falcon 24-well multitrays
(BD Biosciences, Franklin Lakes, NJ, USA). Cells were seeded at
a density of 7× 105 cells/insert and grown in BEGM for 15 days.
Transepithelial electrical resistance (TER) was measured with
an epithelial voltmeter (EVOM; World Precision Instruments,
Sarasota, FL, USA). The cell inserts were used for experiments
when the cell monolayers reached a TER > 1000  × cm2.
The effects of N. arvensis extracts and its pure active principles
(BSS, stigmasterol, and campesterol) were analyzed as elsewhere
described for different chemical compounds (Nicolis et al., 2009;
Borgatti et al., 2011). P. aeruginosa, PAO1 laboratory strain, was
kindly provided by A. Prince (Columbia University, New York).
Bacteria were grown in trypticase soy broth (TSB) or agar (TSA)
(Difco, Detroit, MI, USA) as described (Dechecchi et al., 2008).
Proliferation Assay
IB3-1 or CuFi-1 cells were seeded at a density of 200,000 cells
in 24 well plates in LHC-8 medium in the presence of 5% FBS.
After adhesion, N. arvensis extract was added at serial dilutions
(as indicate in the figures) and incubated for further 24 h or 48 h.
Cells were washed with PBS, detached with trypsin/EDTA and
resuspended in DMEM medium. Finally, cells were counted with
a Sysmex XE-2100 Cytometer.
Anti-bacterial Assay
The anti-microbial activity of N. arvensis extracts was determined
by following the procedure for the Minimum Inhibitory
Concentration (MIC) of the Clinical and Laboratory Standards
Institute (CLSI), former National Committee for Clinical
Laboratory Standards (NCCLS). Briefly, P. aeruginosa (PAO1
strain) was cultured on agar plates of TSA overnight at 37◦C.
The range of N. arvensis extract concentration tested (as indicated
in the figure) was prepared in 15 ml tubes containing 5 ml of
TSB. A McFarland 0.5 standard concentration of P. aeruginosa
(20 µl) was added to each tube and the samples were incubated
at 37◦C for 24 h. MIC is defined as the lowest concentration of
compound at which there is no visible organism growth. In order
to verify the absence of bacterial growth, the samples were read at
660 nm wavelength for quantitative analysis with a Beckman DU
640 spectrophotometer.
Adherence of PAO1 to IB3-1 Cells
PAO1 were metabolically labeled with [35S]-methionine
according to (Saiman and Prince, 1993) with minor changes,
as described (Dechecchi et al., 2008). Colonies of PAO1 from
overnight TSA plates were inoculated M9 (Difco, Detroit, MI,
USA) medium and grown at 37◦C with shaking to a density
of 108 CFU/ml. 100 mCi/ml [35S] methionine (Amersham
Biosciences, Uppsala, Sweden) was added to the broth and
incubated at 37◦C with shaking for 30 min. Bacteria were
then washed twice with 10 mM NaCl and resuspended in PBS.
Aliquots of bacterial suspension were plated and scintillations
counted to calculate the number of bacteria associated with the
counts per minute (CFU/cpm). Specific activity ranged between
40 and 1000 CFU/cpm. Metabolically labeled PAO1 were added
to monolayers of IB3-1 cells and incubated at room temperature
for 60 min. Unbound organisms were rinsed off the monolayers
with three successive PBS washes. Cells and adherent bacteria
were solubilized in 0.5 ml of 2% SDS and scintillations were
counted. Specific binding was calculated by subtracting counts
obtained in the presence of 100-fold excess unlabelled PAO1.
Non-specific binding was about 30% of total.
Quantitative Gene Expression Analyses
by qRT-PCR
Total RNA from IB3-1 and CuFi-1 cells was purified using a
High Pure RNA Isolation Kit (Roche, Mannheim, Germany),
and 2.0 µg RNA were reverse transcribed to cDNA using the
High Capacity cDNA Archive Kit and random primers (Applied
Biosystems, Foster City, CA, USA) in a final reaction volume
of 20 µl. For the Real-time qPCR, 5 µl of cDNA were used
for each SYBR Green real-time PCR to quantify the relative
gene expression. The cDNA (5 µl) was then amplified for 40
PCR cycles using the SYBR Green PCR Master Mix (Applied
Biosystems) in a 25 µl reaction using 7900HT Fast Real-Time
PCR apparatus (Applied Biosystems, Foster City, CA, USA).
In order to perform the PCR reaction QuantiTect Primer
assays (Qiagen, Hilden, Germany) for IL-8 (Hs_IL8_1_SG,
NM_000584), GRO-α (Hs_CXCL1_1_SG, NM_001511), GRO-β
(Hs_CXCL3_1_SG, NM_002090), ICAM-1 (Hs_ICAM1_1_SG,
NM_000201), IL-6 (Hs_IL6_1_SG, NM_000600), TNF-α
(Hs_TNF_1_SG, NM_000594), IFN-γ (Hs_IFNG_1_SG,
NM_000619), IP-10 (Hs_CXCL10_1_SG, NM_001565), LPO
(Hs_LPO_1_SG, NM_006151), DEFB2 (Hs_DEFB2_1_SG,
NM_005218), DEFB4A (Hs_DEFB4A_1_SG, NM_004942), IL-
1β (hS_IL1B_1_SG, NM_00576), GAPDH (HS_GAPDH_1_SG,
NM_002046) were purchased. Changes in mRNA expression
level were calculated following normalization with the GAPDH
calibrator gene. Results were collected with SDS 2.3 software
(Applied Biosystems), and relative quantification was performed
using the Ct method. Data were analyzed with RQ Manager
software 1.2 (Applied Biosystems).
Quantitative Expression Cytokine
Release
IB3-1 cells seeded on 24 wells Petri dishes were treated with
vehicle alone or BSS for 16 h and then infected with PAO1 for
Frontiers in Pharmacology | www.frontiersin.org 4 May 2017 | Volume 8 | Article 236
fphar-08-00236 May 10, 2017 Time: 15:0 # 5
Lampronti et al. β-Sitosterol Reduces IL-8 in CF Cells
FIGURE 2 | Effect of N. arvensis extracts in IB3-1 cells. (A) Effect of N. arvensis extracts on IL-8 mRNA expression in IB3-1 cells. IB3-1 cells were treated with
the chloroform extract (solved in EtOH/DMSO 95/5) (A) at different concentrations (0.1–200 µg/ml) for 16 h before infection with PAO1 (100 CFU/cell) for further 4 h.
IL-8 mRNA expression was quantified by qRT-PCR. Expression of IL-8 mRNA was measured by Real-Time qPCR and obtained by comparing the ratio IL-8 and the
housekeeping gene GAPDH between non-infected and infected cells. The results are expressed as the % of untreated cells. Data are mean ±SEM of three
independent experiments performed in duplicate. Dashed line corresponds to cells treated with solvent alone. (B) Effect of N. arvensis extract in PAO1 infected IB3-1
cells after different incubation times. The N. arvensis extract (10 µg/ml) was added to IB3-1 cells 24, 4, and 2 h before, simultaneously or 2 h post PAO1 infection
(100 CFU/cell). IL-8 mRNA expression was measured as indicated in (A). Data are mean ±SEM of three independent experiments performed in duplicate. Dashed
line corresponds to cells treated with solvent alone. (C) PAO1 growth. Bacteria were cultured overnight at 37◦C in the presence of solvent or ranging doses
(0.1–1000 µg/ml) of N. arvensis extract. Bacterial growth was monitored by absorbance measures at 660 nm. A representative experiment performed in duplicate is
shown. (D) Adhesion of PAO1 to IB3.1 cells. 500,000 IB3-1 cells on Petri dishes, in duplicate, were treated for 24 h with 10 µg/ml N. arvensis extract. Different
amounts of 35S-PAO1, expressed as CFU/well, were added to the wells and incubated as described in section “Materials and Methods”. Data reported in the figure
are the specific binding calculated by subtracting counts obtained in the presence of 100-fold excess of non-labeled PAO1 and are expressed as CFU/well. Data are
mean ±SEM of three independent experiments performed in duplicate. (E) Effects of N. arvensis extracts on cell growth in IB3-1 cells. IB3-1 cells were incubated
with increasing concentrations (1–200 µg/ml) of the chloroform extract (solved in EtOH/DMSO) of N. arvensis for 24 and 48 h. Cell viability was measured by
cytometer analysis. Data are expressed as % control (solvent) and are relative to a representative experiment performed in duplicate. Dashed line corresponds to
cells treated with solvent alone.
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FIGURE 3 | Pseudomonas aeruginosa modulated mRNA expression in IB3-1 cells: effect of N. arvensis extract. IB3-1 cells were treated with the
chloroform extract (10 µg/ml) or solvent alone 16 h before infection with PAO1 (100 CFU/cell) for further 4 h. mRNA expression was measured by real-time qPCR
and obtained by comparing the ratio of target to housekeeping gene GAPDH between non-infected and infected cells.
further 4 h. Quantitative measurement of Il-8 protein release in
the cell medium was measured by the Human IL-8 Instant ELISA
kit (Bender MedSystems, Vienna, Austria). Cytokines released
from CuFi-1 cells into tissue culture supernatants were measured
by Magnetic Luminex Assay (R&D SYSTEMS, Minneapolis, MN,
USA) as suggested by the manufacturer. The Luminex assay
is designed for the multiplexed quantitative measurement of
multiple cytokines in a single well using as little as 50 µl
of sample. In our experiments, the Human Premixed Multi-
Analyte Kit (R&D SYSTEMS) for the IL-8, GRO-α, GRO-β
human cytokines analysis was used. 50 µl of cytokine standards
or samples (supernatants recovered from treated cells) were
incubated with 50 µl of anti-cytokine conjugated magnetic beads
in 96-well plates for 2 h at room temperature with shaking. Plates
were washed three times with 100 µl of Bio-Plex wash buffer
using Bio-Plex Pro-wash Station (Bio-Rad laboratories, Hercules,
CA, USA), 50 µl of diluted detection antibody were added,
and plates were incubated for 1 h at room temperature with
shaking. After three washes, 50 µl of streptavidin-phycoerythrin
was added, and the plates were incubated for 30 min at room
temperature with shaking. Finally, plates were washed three
times, beads were suspended in Bio-Plex wash buffer, and samples
were analyzed on a Bio-Plex 200 Array reader (Bio-Rad). Data
were analyzed with Bio-Pex Manager software (Bio-Rad).
PKCα Translocation and Microscopic
Analysis
IB3-1 cells were seeded and then transfected with the Protein
Kinase C isoform alpha fused to green fluorescence protein
(PKCαGFP), using Lipofectamine LTX, as previously described
(Chiesa et al., 2001). Microscope analysis was performed 36 h
after transfection, P. aeruginosa strain 1:100 CFU was added to
the cells, as shown in the figure. Images of PKCα translocation
were recorded a different time points using a digital imaging
system based on a Zeiss Axiovert 200 fluorescence microscope.
The data were acquired and processed using the MetaMorph
analysis program (Universal Imaging). The recruitment of the
kinase is represented as plasma membrane translocation of
PKCαGFP, expressed as percentage of the increase in fluorescence
ratio with respect to time 0 (calculated as the ratio of
plasma membrane and cytosol average intracellular fluorescence,
obtained from multiple regions inside the cytosol and on the cell
membrane, measured on single cell). The values are expressed as
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FIGURE 4 | Effect of BSS on PAO1-stimulated IL-8 expression in IB3-1
cells. (A) IB3-1 cells were treated with ranging doses (1–100 nM) of BBS for
16 h and infected with PAO1 for further 4 h. IL-8 mRNA expression was
measured as indicated in the legend of Figure 2. The results are expressed as
the % of untreated cells. Data are mean ± SEM of three independent
experiments performed in duplicate. (B) IB3-1 cells were treated with 100 nM
BSS for 16 h and infected with PAO1 for further 4 h. IL-8 release in the
supernatant was measured by ELISA assay. Representative experiment
performed in duplicate.
fold change vs. uninfected PAO1 control cells (0 min), referred
as 100%. Indeed, the PKCα translocation was quantified by using
representative line scan profile of fluorescence intensity across the
cell, indicated by white diagonal lines in “0 min” and “60 min”
images reported in the figure.
Statistics
Results are expressed as mean ± standard error of the mean
(SEM). Comparisons between groups were made by using
Student’s t-test. Statistical significance was defined for ∗p < 0.05,
∗∗p< 0.01, ∗∗∗p< 0.001.
RESULTS
Major Chemical Composition of
N. arvensis Extract
Chloroform extract from milled N. arvensis seeds was analyzed.
Several chemical compounds were identified as principal
constituents of N. arvensis extracts, including BSS, stigmasterol,
and campesterol (Figure 1). This identification procedure
was performed by GC-MS analysis of chloroform extracts of
N. arvensis. BSS, stigmasterol, and campesterol are phytosterols,
cholesterol-like molecules found in plant material with the
highest concentrations occurring in vegetable oils. Phytosterols
act as structural components in the vegetal cell membrane, a role
that is played by cholesterol in mammalian cells. The extraction
yield was 0.94%. The chemical fingerprinting of N. arvensis
extracts was achieved by GC-MS. The main phytosterols were
identified by comparison between the experimental peaks and
the standards molecules peaks analyzed with the same technique.
The phytocomplex obtained by the chloroform extraction
exhibited an important phytosterols component, constituted
by stigmastan-3,5-diene (tentatively identified), campesterol,
stigmasterol, and BSS, the latter being the most abundant
compound, as reported in Table 1.
Inhibition of IL-8 mRNA Expression in
IB3-1 Cells Infected by P. aeruginosa and
Treated with N. arvensis Extract
In order to study the possible anti-inflammatory effect of
N. arvensis seeds, we firstly tested different concentrations of the
extract in CF bronchial epithelial IB3-1 cells infected with the
P. aeruginosa laboratory strain PAO1. The neutrophil chemokine
IL-8 transcript was quantified. As shown in Figure 2A, the extract
significantly inhibited, the PAO1-dependent transcription of IL-
8 in IB3-1 cells by approximately 50%, starting from 2 µg/ml.
The inhibitory effect of the N. arvensis extract was tested after
different incubation times. The N. arvensis extract (10 µg/ml)
was added to IB3-1 cells 24, 4, and 2 h before, simultaneously
or 2 h post PAO1 infection (100 CFU/cell). The inhibitory effect
was confirmed in all these conditions, as shown in Figure 2B.
These findings indicate that extract of N. arvensis seeds reduces
the inflammatory response to P. aeruginosa in CF bronchial
cells.
Extract from N. arvensis Has No Effect
on Cell Growth in IB3-1 Cells
In order to exclude possible adverse effects on cell cycle, cell
growth was studied in IB3-1 cells treated with the extract
(1–200 µg/ml) for 24 or 48 h. No changes in cell growth were
observed in IB3-1 cells treated with the N. arvensis extract
(Figure 2E), also at high concentration (200 µg/ml). These
data indicate that the extract of N. arvensis does not affect the
proliferation of IB3-1 cells.
Extract from N. arvensis Does Not Affect
PAO1 Growth and Adherence to IB3-1
Cells
To exclude that the inhibition of P. aeruginosa-dependent
induction of IL-8 was due to an indirect anti-bacterial effect on
P. aeruginosa, we performed an anti-bacterial assay following the
procedure for the MIC. Bacteria were cultured overnight at 37◦C
in the presence of solvent or ranging doses (0.1–1000 µg/ml)
of N. arvensis extract. As shown in Figure 2C, no effect on
Frontiers in Pharmacology | www.frontiersin.org 7 May 2017 | Volume 8 | Article 236
fphar-08-00236 May 10, 2017 Time: 15:0 # 8
Lampronti et al. β-Sitosterol Reduces IL-8 in CF Cells
FIGURE 5 | Effect of BSS on IL-8 mRNA, bacterial growth and cell viability in CuFi-1 cells. Cells were treated for 16 h with BSS (100 nM) and infected with
PAO1 for further 4 h. IL-8 mRNA expression was measured as indicated in the legend of Figure 2. (A) Basal IL-8 mRNA expression. Data are expressed as relative
to the expression of GAPDH housekeeping gene. (B) PAO1-stimulated mRNA expression. Data are expressed as relative to not infected cells. (C) PAO1 growth.
Bacteria were cultured overnight at 37◦C in the presence of solvent or ranging doses (0.1– 200 µM) of BSS. Bacterial growth was monitored by absorbance
measures at 660 nm. A representative experiment performed in duplicate is shown. (D) Cell viability. CuFi-1 cells were treated with solvent alone or BSS
(0.01–200 µM) for 24 and 48 h. Cell viability was recorded by cytometer analysis. Data are expressed as % control (solvent) and are relative to a representative
experiment performed in duplicate. Dashed line corresponds to cells treated with solvent alone.
bacterial growth was found, indicating that N. arvensis does not
possess significant anti-bacterial activity on the Gram-negative
bacterium P. aeruginosa. Considering that many pathogenic
microorganisms use glycoconjugate receptors to establish contact
with the host tissues (McNamara et al., 2006), the inhibition
of biosynthesis of these receptors may have a major impact on
the pathogenesis of infection and, consequently, on the host
response induced by infection. Therefore, the anti-inflammatory
effect of N. arvensis extract observed in IB3-1 cells could reflect
the reduced expression of glycolipid receptors for PAO1. To
evaluate this possibility, adherence of metabolically labeled [35S]
methionine-PAO1 was measured in IB3-1 cells, treated or not
for 24 h with the extract of N. arvensis (10 µg/ml). Figure 2D
shows a dose-dependent increase of PAO1 binding to the cells,
no significant differences due to the treatment with N. arvensis
could be found. These results indicate that incubation with
N. arvensis extract for 24 h does not affect the adherence of
PAO1 to IB3-1 cells, thus suggesting that the sharp inhibition of
P. aeruginosa-dependent IL-8 transcription after treatment with
N. arvensis is independent from reduction of bacterial-host cell
interactions.
Extract of N. arvensis Reduces
P. aeruginosa Dependent IL-8 Expression
in IB3-1 Cells
We extended the analysis of the anti-inflammatory effect to
other genes known to be involved in the host–pathogen
interaction in CF bronchial epithelial cells (Dechecchi et al.,
2011). As shown in Figure 3, infection with the P. aeruginosa
strain PAO1 for 4 h up-modulated the expression of the
major neutrophil chemokines IL-8, GRO-α, and GRO-β, of
the mononuclear cells chemokine IP-10, of the adhesion
molecule intercellular adhesion molecule 1 (ICAM-1) involved
in leukocyte chemotaxis, of the cytokines IL-1β, IL-6, TNF-α,
IFN-γ, of the antimicrobial peptides β-defensin-2 (HBD-2)
and -4 (HBD-4) and of lactoperoxidase (LPO). IL-8, the most
abundantly expressed cytokine in the lung of CF patients, was
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FIGURE 6 | Effect of BSS on expression of neutrophil chemokines in CuFi-1 cells. (A) CuFi-1 cells were treated for 16 h with solvent alone or 100 nM BSS
and then infected by PAO1 (10–50 CFU/cell) for 4 h. mRNA expression was measured as indicated in the legend of Figure 2. (B–D) Release of the neutrophil
chemokines IL-8, Groα, and GROβ in the supernatants of CuFi-1 cells were measured by Bio-plex assay. CuFi-1 cells were treated as described for (A).
Representative of at least three experiments performed in duplicate.
the only one gene to be significantly inhibited by the extract of
N. arvensis in this cell model, as shown in Figure 3.
BSS Reduces P. aeruginosa-Dependent
Inflammatory Response in CF Bronchial
Epithelial Cells
β-sitosterol, stigmasterol, and campesterol were the three major
compounds identified in the extract from the seeds of N. arvensis,
as shown in Figure 1. These compounds were purchased and
tested in IB3-1 cells in order to identify those reproducing
the anti-inflammatory activity observed with the whole extract.
The IB3-1 cells were treated with increasing doses, starting
from 1 nM BSS, stigmasterol, and campesterol for 16 h before
infection with PAO1. As shown in Figure 4A, BSS significantly
inhibited the PAO1-dependent transcription of IL-8, starting
from 10 nM concentration. No effect on the transcription of IL-8
was found in cells treated with stigmasterol or campesterol (data
not shown). In order to check whether changes in IL-8 mRNA
was directly translated into protein level, secretion of IL-8 protein
was measured in cell supernatants. As shown in Figure 4B,
BSS (100 nM) strongly inhibited IL-8 release in IB3-1 cells. The
effect of BSS in IB3-1 cells was verified in CuFi-1 bronchial
epithelial cells. As shown in Figure 5, BSS (100 nM) significantly
reduces the expression of IL-8 mRNA induced by P. aeruginosa
(Figure 5B). No significant effect of BSS only on IL-8 expression
in basal uninfected cells was observed (Figure 5A). The effect
of BSS on the inflammatory response to PAO1 was extended to
the analysis of the other major neutrophil chemokines GRO-α,
GRO-β. BSS significantly reduced the P. aeruginosa-dependent
expression of the neutrophil chemokines IL-8, GRO-α, and
GRO-β, both at transcript (Figure 6A) and protein levels
(Figures 6B–D). BSS did not change the basal chemokine release.
BSS Does Not Interfere with Bacterial
Growth and Cell Viability
It has been recently reported that BSS extracted from the roots of
Caylusea abyssinica has a moderate antibacterial activity against
P. aeruginosa, Staphylococcus aureus, and Escherichia coli (Edilu
et al., 2015). In order to verify whether the anti-inflammatory
effect of BSS was due to its antibacterial property, we measured
PAO1 growth in the presence of increasing concentration of
BSS (from 0.01 to 200 µM). Figure 5C shows that BSS did not
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FIGURE 7 | Effect of BSS on PKCα translocation. IB3-1 cells were seeded and then transfected with the Protein Kinase C isoform α fused to green fluorescence
protein (PKCαGFP). Microscope analysis was performed 36 h after transfection, P. aeruginosa strain 1:100 CFU was added to the cells, as shown in the figure.
(A) Images of PKCα translocation on the plasma membrane in the presence of P. aeruginosa strain PAO1 in cells pre-treated with BSS or solvent alone (vehicle).
PKCα translocation was quantified by using line scan profile of fluorescence intensity across the cell, indicated by white diagonal lines in “0 min” and “60 min”
images. The graphs show the comparison between the PKCαGFP fluorescence intensity profiles, expressed as fluorescent arbitrary units (F.a.u.), at 0 min and
60 min of PAO1 infection in cells pre-treated with vehicle and BSS, respectively. The asterisks indicate the edge of the cell indicative of plasma membrane. The
arrows designate the enriched PKCαGFP signal at the plasma membrane in cells pre-treated with vehicle after 60 min of pathogen infection, confirming the plasma
membrane translocation of PKCαGFP. (B) The recruitment of the kinase is expressed as percentage of the increase in fluorescence ratio with respect to time 0 of
pathogen infection, calculated as the ratio of plasma membrane and cytosol average intracellular fluorescence intensity, obtained from multiple regions inside the
cytosol and on the cell membrane, measured on single cell. The values are expressed as fold change vs. un-infected PAO-1 control cells (0 min), referred as 100%.
inhibit bacterial growth, at least in our experimental conditions.
Therefore, We studied the cell viability of CuFi-1 cells treated
with the solvent alone or increasing doses of BSS (0.01–200 µM)
for 24 and 48 h. Data shown in Figure 5D demonstrate a cytotoxic
effect of BSS only at doses higher than 150 µM.
BSS Reduces the Activation of Protein
Kinase C α Isoform Induced by
P. aeruginosa
We previously observed that P. aeruginosa interacting with Toll-
like Receptors 5 and 2 induces a pro-inflammatory cascade and
activation of the intracellular Ca2+ pathway in which PLCB3 and
PKC play key regulatory roles (Bezzerri et al., 2011b). We verified
a potential effect of BSS on this latter pathway by investigating its
effect on the translocation of the Ca2+-dependent PKCα isoform
in IB3-1 cells. As shown in Figure 7, BSS (100 nM) significantly
reduces the extent of translocation of PKCα to the plasma
membrane from 30 to 60 min after P. aeruginosa exposure.
DISCUSSION AND CONCLUSIONS
The urgency of finding more effective anti-infectious and anti-
cancer drugs has newly opened the strategy of drug repurposing,
which is aimed to discover new pharmaceutical activities for
“old” clinically used drugs. A wide source of molecules for
drug repurposing can be found within the natural products
of traditional medicine, which provided for many decades
significant hints to discover important drugs, that are still in
use in several human diseases (for review see Cragg et al.,
2014 and Newman and Cragg, 2016). In search of novel
anti-inflammatory molecules to reduce the adverse effects of
chronic lung inflammation in CF patients, we were inspired by
serendipity on the potential activities of black seeds collected
from the deserts of Northern Africa (Morocco) and distributed
by Berber pharmacists (Supplementary Text S1). However, safety
issues referred to the straight use of extracts from natural
products have been raised (Ekor, 2014), which prompted us to
identify and test the major single chemical compounds extracted
from this natural product.
We focused here on extract from the black seeds of N. arvensis.
Few data have been reported on “N. arvensis,” e.g., the online
PubMed search only recalls seven articles, suggesting mainly
generic antimicrobial and anti-inflammatory activities (Landa
et al., 2009). Here we found that the extract of N. arvensis has
anti-inflammatory activity in bronchial epithelial cells exposed
to the Gram-negative bacterium P. aeruginosa (Figures 2, 3), a
classical model system to test relevant molecules for CF lung
inflammation. We excluded an artifactual effect on cell viability
(Figure 2E) and, being the chloroform extract of N. arvensis
active on Gram-positive bacteria (Landa et al., 2009), we also
excluded that the anti-inflammatory effect could be mediated by
an anti-bacterial activity or by inhibition of bacterium binding
to the bronchial epithelial cells (Figures 2C,D). We focused on
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the three most abundant components extracted with chloroform,
which were validated with their pure standards (Table 1), namely
BSS, stigmasterol, and campesterol (Figure 1), which are the
three most abundant sterols deriving from plants (Valitova
et al., 2016). Since plant sterols have been widely tested for
efficacy and safety in clinical pharmacology of highly relevant
human diseases, such as dyslipidemia related to atherosclerosis,
and since consensus has been reached on the absence of
adverse signals in large scale clinical trials (Gylling et al., 2014),
we felt justified in pursuing a repurposing strategy toward
CF lung inflammation. Moreover, different mixtures of these
plant sterols have been found of potential immunomodulatory
effect (Bouic and Lamprecht, 1999; Bouic, 2002; Yuk et al.,
2007).
We found that BSS (100 nM) significantly reduced the
expression of the major neutrophilic chemokines IL-8, GRO-
α, and GRO-β in human bronchial epithelial cells challenged
with P. aeruginosa. This is consistent with a seminal observation
showing that BSS partly reduces IL-8 in skin fibroblasts
challenged with retinoic acid (Kim et al., 2003). How could we
possibly explain the effect of BSS on neutrophilic chemotaxis?
A plant-derived sterol mixture including BSS was found to
inhibit the recruitment of neutrophils in a murine model of
carrageenan-induced inflammation in vivo (Navarro et al., 2001).
The effects of BSS on pro-inflammatory signal transduction
have not been extensively investigated, the only hint being
that BSS was found to inhibit the active form of the
PKCα in prostate-derived cells (Kassen et al., 2000). Here
we found that BSS partly reduces the activation of the
PKCα isoform in a completely different model, namely
the bronchial epithelial cells challenged with P. aeruginosa
(Figure 7), which we found involved with a relevant pro-
inflammatory role in the Ca2+-dependent signaling machinery,
leading to IL-8 gene expression induced by P. aeruginosa
in CF bronchial epithelial cells (Bezzerri et al., 2011b). The
role of BSS in the organization of lipid rafts of plasma
membranes and in the modulation of ceramide (Beck et al.,
2007; Ha¸c-Wydro, 2013; Grosjean et al., 2015) also opens
interesting insights in relation to sphingolipid metabolism and
inflammation in CF lung disease (for review see Aureli et al.,
2016).
Taken together, these results suggest that pharmaceutically
relevant concentrations of BSS are promising in down-
modulating the key neutrophil chemokines strongly induced in
bronchial epithelial cells derived from CF patients upon response
to P. aeruginosa in vitro (Bezzerri et al., 2011a; Prandini et al.,
2016). The large use of BSS in controlled clinical trials, presenting
a satisfactory safety profile for long term use (Gylling et al., 2014),
stimulates to investigate further on the mechanism(s) of action
of this molecule in the CF respiratory models, both in vitro
and in vivo, for potential application as an anti-inflammatory
molecule complementary to CFTR gene-directed modulators.
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